That is, the level of TMPRSS2 expression and methylation are basically the same in the two lung cancer subtypes, so we believe that the difference between TMPRSS2 on LUAD and LUSC prognosis was also not at the methylation level. This evidence concerns the gene TMPRSS2 and lung carcinoma.